Advertisement
Singapore markets closed

  • Straits Times Index

    3,290.70
    +24.75 (+0.76%)
     

  • Nikkei

    38,229.11
    +155.13 (+0.41%)
     

  • Hang Seng

    18,963.68
    +425.87 (+2.30%)
     

  • FTSE 100

    8,433.76
    +52.41 (+0.63%)
     

  • Bitcoin USD

    60,858.29
    -1,956.15 (-3.11%)
     

  • CMC Crypto 200

    1,261.26
    -96.74 (-7.12%)
     

  • S&P 500

    5,222.68
    +8.60 (+0.16%)
     

  • Dow

    39,512.84
    +125.08 (+0.32%)
     

  • Nasdaq

    16,340.87
    -5.40 (-0.03%)
     

  • Gold

    2,366.90
    +26.60 (+1.14%)
     

  • Crude Oil

    78.20
    -1.06 (-1.34%)
     

  • 10-Yr Bond

    4.5040
    +0.0550 (+1.24%)
     

  • FTSE Bursa Malaysia

    1,600.67
    -0.55 (-0.03%)
     

  • Jakarta Composite Index

    7,088.79
    -34.81 (-0.49%)
     

  • PSE Index

    6,511.93
    -30.53 (-0.47%)
     

Has Endo International plc (ENDP) Outpaced Other Medical Stocks This Year?

Zacks Equity Research
Updated
Is (AMTD) Outperforming Other Finance Stocks This Year?

Investors focused on the Medical space have likely heard of Endo International plc (ENDP), but is the stock performing well in comparison to the rest of its sector peers? One simple way to answer this question is to take a look at the year-to-date performance of ENDP and the rest of the Medical group's stocks.

Endo International plc is a member of our Medical group, which includes 756 different companies and currently sits at #5 in the Zacks Sector Rank. The Zacks Sector Rank includes 16 different groups and is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors.

The Zacks Rank is a proven system that emphasizes earnings estimates and estimate revisions, highlighting a variety of stocks that are displaying the right characteristics to beat the market over the next one to three months. ENDP is currently sporting a Zacks Rank of #2 (Buy).

Over the past 90 days, the Zacks Consensus Estimate for ENDP's full-year earnings has moved 10.32% higher. This is a sign of improving analyst sentiment and a positive earnings outlook trend.

ADVERTISEMENT

According to our latest data, ENDP has moved about 115.48% on a year-to-date basis. Meanwhile, stocks in the Medical group have gained about 11.50% on average. This means that Endo International plc is performing better than its sector in terms of year-to-date returns.

Looking more specifically, ENDP belongs to the Medical - Drugs industry, which includes 161 individual stocks and currently sits at #102 in the Zacks Industry Rank. This group has gained an average of 6.18% so far this year, so ENDP is performing better in this area.

Going forward, investors interested in Medical stocks should continue to pay close attention to ENDP as it looks to continue its solid performance.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Endo International plc (ENDP) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.